Pembrolizumab in Elderly Patients With Advanced Lung Cancer
NCT03293680
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
83
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG:
Pembrolizumab
Sponsor
Spanish Lung Cancer Group